Levodopa (L-dopa)

DRUG2 trials

Sponsors

Biotie Therapies Inc., Beth Israel Deaconess Medical Center

Conditions

Parkinson's Disease

Phase 2

Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off

CompletedNCT01283594

Biotie Therapies Inc.Parkinson's Disease

Start: 2011-03-31End: 2012-10-31Updated: 2019-01-17

Phase 4

Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics

Not yet recruitingNCT07793461

Beth Israel Deaconess Medical CenterParkinson's Disease

Start: 2027-07-01End: 2030-12-01Target: 40Updated: 2026-08-28

Related Papers

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.

2014-07-0698 citations